Revolution Medicines, Inc. is 16.7x more valuable than NOVAVAX INC by market capitalization ($30.65 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVAX | RVMD |
|---|---|---|
| Market cap | $1.84 B | $30.65 B |
| US-listed rank | #2165 | #454 |
| Revenue (latest FY) | $1.12B | $0.00 |
| Net income (latest FY) | $440.30M | -$1.13B |
| Net margin | 39.2% | - |
| P/E (trailing FY) | 4.2 | - |
| SEC filings | 1,627 | 782 |
Revolution Medicines, Inc. is 16.7x more valuable than NOVAVAX INC by market capitalization ($30.65 B vs $1.84 B).
In their latest fiscal years, NOVAVAX INC reported $1.12B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: NOVAVAX INC and Revolution Medicines, Inc., or browse the full rankings.